ADiag: Graph Theory and Deep Learning Based Diagnosis of Alzheimer's Disease
ISEF · 2021 Translational Medical Science Fourth Award
Overview
Alzheimer’s Disease (AD) is the most widespread neurodegenerative disease, affecting over 50 million people across the world. While its progression cannot be stopped, early and accurate diagnostic testing can drastically improve quality of life in patients. Currently, only qualitative means of testing are employed in the form of scoring performance on a battery of cognitive tests. The inherent disadvantage of this method is that the burden of an accurate diagnosis falls on the clinician’s competence. Quantitative methods like MRI scan assessment are inaccurate at best, due to the elusive nature of visually observable changes in the brain. In lieu of these disadvantages to extant methods of AD diagnosis, we have developed ADiag, a novel quantitative method to diagnose AD through graph theory and deep learning based analysis of large graphs based on thickness differences between different structural regions of the cortex. ADiag is adept not only at differentiating between controls and AD patients, but also at predicting progression of Mild Cognitive Impairment (MCI) to clinical AD.
Awards (1)
- Fourth Award of $500 $500
Competition history
- ISEF 2021
Resources
Related projects
ISEF · 2024
Alzheimer's Recognition Using Artificial Intelligence
ISEF · 2020
Predicting the Onset of Alzheimer's Disease Using Graph Neural Networks and Diffusion Tensor Imaging
ISEF · 2025
Promoting Equity: A Novel GAN-Based Framework for Improved MRI-Based Alzheimer's Diagnosis Utilizing Multiple Deep Learning Architectures
ISEF · 2025
Advancing Alzheimer's Diagnosis With AH_Ad: A Classification Model Based on MRI Images
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair